Company: BIVIW
Filing Date: 2025-11-10
Form Type: 10-Q
Source: 0001520138-25-000343
Chunk: 2

Company: BIOVIE INC.
Filing Date: 2025-11-10
Form: 10-Q
Item: Part I, Item 1
Chunk 2
---
 $(4,477,073)

    NET LOSS PER COMMON SHARE 

    - Basic 
    $(0.98) 
    $(7.00)
  
    - Diluted 
    $(0.98) 
    $(7.00)

    WEIGHTED AVERAGE NUMBER OF COMMON  SHARES OUTSTANDING 

    - Basic 
     5,214,355  
     639,836 
  
    - Diluted 
     5,214,355  
     639,836 

    NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS 
    $(5,131,101) 
    $(4,477,073)

See accompanying notes to unaudited condensed financial
statements

5

Table of Contents 

BioVie Inc.

Condensed Statements of Changes in Stockholders’
Equity 

(Unaudited)

    Accumulated  

    Additional  

    Other  
       
    Total 

    Common Stock  
    Common Stock  
    Paid in  
    Treasury Stock  
    Treasury Stock  
    Comprehensive  
    Accumulated  
    Stockholders' 

    Shares  
    Amount  
    Capital  
    Shares  
    Amount  
    Income  
    Deficit  
    Equity 
  
    Balance, June 30, 2024 
     621,640  
    $62  
     349,738,841  
     (2,633) 
    $(27) 
    $-  
    $(334,232,661) 
    $15,506,215 

    Stock-based compensation - stock options 
     -  
     -  
     118,898  
     -  
     -  
     -  
     -  
     118,898 

    Stock-based compensation - restricted stock units 
     -  
     -  
     301,491  
     -  
     -  
     -  
     -  
     301,491 

    Issuance of common stock from vesting of - restricted stock units 
     341  
     -  
     -  
     -  
     -  
     -  
     -  
     - 

    Stock-based compensation - issuance of common stock for